These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4047510)

  • 1. Brain and blood levels of bismuth after oral or parenteral administration of tripotassium-dicitrato bismuthate to rats.
    Abbracchio MP; Balduini W; Cavallaro A; Adamoli P; Fittipaldi M; Muzio F; Malandrino S; Cattabeni F
    Neurotoxicology; 1985; 6(3):139-43. PubMed ID: 4047510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bismuth concentration in blood and urine of children treated with ventrisol (polfa) preliminary study.
    Iwańczak F; Rajska H; Iwańczak B; Górecka H
    Rocz Akad Med Bialymst; 1995; 40(3):685-91. PubMed ID: 8775327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J; Ho J; Lam SK; Wong J; Ong GB
    Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the absorption and excretion of tripotassium dicitrato-bismuthate in man.
    Lee SP
    Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):359-64. PubMed ID: 7335960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ultrastructural localisation of De-Nol (colloidal tripotassium dicitrato-bismuthate--TDB) in the upper gastrointestinal tract of man and rodents following oral and instrumental administration.
    Coghill SB; Hopwood D; McPherson S; Hislop S
    J Pathol; 1983 Feb; 139(2):105-14. PubMed ID: 6827397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
    Lane M; Lee S; Tasman-Jones C; Nicholson G
    N Z Med J; 1985 Mar; 98(775):191-2. PubMed ID: 3885084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of plasma bismuth levels after oral dosing with basic bismuth carbonate or tripotassium dicitrato bismuthate.
    Madaus S; Schulte-Frohlinde E; Scherer C; Kämmereit A; Schusdziarra V; Classen M
    Aliment Pharmacol Ther; 1992 Apr; 6(2):241-9. PubMed ID: 1288519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate.
    Gavey CJ; Szeto ML; Nwokolo CU; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 1989 Feb; 3(1):21-8. PubMed ID: 2491455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel means of comparing the bioequivalence of two formulations of tripotassium dicitrato bismuthate (De-Noltab).
    Coghill SB; Shepherd AN
    Postgrad Med J; 1988 Oct; 64(756):761-3. PubMed ID: 3255916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice daily tripotassium dicitrato bismuthate in the treatment of duodenal ulceration.
    Hollanders D
    Postgrad Med J; 1986 Jan; 62(723):19-21. PubMed ID: 3540918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
    Lacey LF; Frazer NM; Keene ON; Smith JT
    Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
    Hamilton I; Worsley BW; O'Connor HJ; Axon AT
    Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of tripotassium dicitrato bismuthate with macrophages in the rat and in vitro.
    Soutar RL; Coghill SB
    Gastroenterology; 1986 Jul; 91(1):84-93. PubMed ID: 3710085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripotassium dicitrato bismuthate: absorption and urinary excretion of bismuth in patients with normal and impaired renal function.
    Treiber G; Gladziwa U; Ittel TH; Walker S; Schweinsberg F; Klotz U
    Aliment Pharmacol Ther; 1991 Oct; 5(5):491-502. PubMed ID: 1793780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bismuth induced encephalopathy caused by tri potassium dicitrato bismuthate in a patient with chronic renal failure.
    Playford RJ; Matthews CH; Campbell MJ; Delves HT; Hla KK; Hodgson HJ; Calam J
    Gut; 1990 Mar; 31(3):359-60. PubMed ID: 2323603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole-induced increase in the absorption of bismuth from tripotassium dicitrato bismuthate.
    Treiber G; Walker S; Klotz U
    Clin Pharmacol Ther; 1994 May; 55(5):486-91. PubMed ID: 8181192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tissue binding of orally administered bismuth in the rat. Effect of the digestive microbial flora].
    Jeanrot R; Chaleil D; Allain P; Papillon C; Raynaud G; Bouvet P
    Toxicol Eur Res; 1982 Jul; 4(4):181-5. PubMed ID: 7157361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and efficacy of tripotassium dicitrato bismuthate (De-Nol) maintenance therapy in patients with duodenal ulceration.
    Dunk AA; Prabhu U; Tobin A; O'Morain C; Mowat NA
    Aliment Pharmacol Ther; 1990 Apr; 4(2):157-62. PubMed ID: 2104081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of gastric mucosal lesions in rats by tri-potassium di-citrato bismuthate.
    Malandrino S; Campagnoli G; Borsa M; Guidoboni R; Tonon GC
    Arzneimittelforschung; 1984; 34(1):30-1. PubMed ID: 6367754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of evidence of neurotoxicity following 8 weeks of treatment with tripotassium dicitrato bismuthate.
    Nwokolo CU; Fitzpatrick JD; Paul R; Dyal R; Smits BJ; Loft DE
    Aliment Pharmacol Ther; 1994 Feb; 8(1):45-53. PubMed ID: 8186346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.